{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:57:23Z","timestamp":1790913443020,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":194,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101329","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:27:00Z","timestamp":1785338820000},"page":"101329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expression of PCAT19, miR-195, ITGA6, and E-cadherin in prostate cancer: a preliminary tissue-based study"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-1608","authenticated-orcid":false,"given":"Samia","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr A.","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam F.A.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Sameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Barakat","family":"Waley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma A.","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa I.","family":"Aboafya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moamen","family":"Amgd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Algazeery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ctarc.2026.101329_bib0001","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.70010","article-title":"Consensus-built recommendations to improve prostate cancer outcomes: a summary of the American cancer society prostate cancer collaborative","volume":"131","author":"Sanders","year":"2025","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.ctarc.2026.101329_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214257","article-title":"Complexities of prostate cancer","volume":"23","author":"Wasim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101329_bib0003","doi-asserted-by":"crossref","first-page":"393","DOI":"10.31557\/apjcb.2025.10.2.393-400","article-title":"Epidemiological analysis of prostatic cancer: incidence, prevalence, mortality, and disability burden in middle eastern countries","volume":"10","author":"Ayyad","year":"2025","journal-title":"Asian. Pac. J. Cancer Biol."},{"key":"10.1016\/j.ctarc.2026.101329_bib0004","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/ijms22041551","article-title":"Treating prostate cancer by antibody\u2013drug conjugates","volume":"22","author":"Rosellini","year":"2021","journal-title":"Int. J. Mol. Sc"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101329_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221775","article-title":"Global incidence of prostate cancer in developing and developed countries with changing age structures","volume":"14","author":"Teoh","year":"2019","journal-title":"PLoS. One"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101329_bib0006","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/medsci8030028","article-title":"Epidemiology, staging and management of prostate cancer","volume":"8","author":"Barsouk","year":"2020","journal-title":"Med. Sci."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101329_bib0007","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/nu13020496","article-title":"Dietary factors and prostate cancer development, progression, and reduction","volume":"13","author":"Oczkowski","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ctarc.2026.101329_bib0008","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ctrv.2018.07.001","article-title":"Tobacco smoking and survival after a prostate cancer diagnosis: a systematic review and meta-analysis","volume":"70","author":"Darcey","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101329_bib0009","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/cancers13030546","article-title":"Bone targeting agents in patients with metastatic prostate cancer: state of the art","volume":"13","author":"Mollica","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101329_bib0010","article-title":"Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: a meta-analysis of prospective clinical trials","volume":"222","author":"Rizzo","year":"2021","journal-title":"Pathol Res Pr."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101329_bib0011","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA, J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101329_bib0012","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajur.2018.11.007","article-title":"Diagnosis of prostate cancer","volume":"6","author":"Descotes","year":"2019","journal-title":"Asian J. Urol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101329_bib0013","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euo.2023.12.005","article-title":"Comparing the performance of digital rectal examination and prostate-specific antigen as a screening test for prostate cancer: a systematic review and meta-analysis","volume":"7","author":"Matsukawa","year":"2024","journal-title":"Eur. Urol. Oncol."},{"issue":"24","key":"10.1016\/j.ctarc.2026.101329_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413519","article-title":"An insight on novel molecular pathways in metastatic prostate cancer: a focus on DDR, MSI and AKT","volume":"22","author":"Mollica","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11010-020-03889-2","article-title":"The development and controversy of competitive endogenous RNA hypothesis in non-coding genes","volume":"476","author":"Lin","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ctarc.2026.101329_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104429","article-title":"PCAT1: an oncogenic lncRNA in diverse cancers and a putative therapeutic target","volume":"114","author":"Ghafouri-Fard","year":"2020","journal-title":"Exp. Mol. Pathol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101329_bib0017","doi-asserted-by":"crossref","first-page":"12810","DOI":"10.1002\/jcb.28552","article-title":"lncRNA PCAT19 promotes the proliferation of laryngocarcinoma cells via modulation of the miR-182\/PDK4 axis","volume":"120","author":"Xu","year":"2019","journal-title":"J. Cell Biochem."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101329_bib0018","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s13258-020-01003-w","article-title":"Suppression of long non-coding RNA PCAT19 inhibits glioma cell proliferation and invasion, and increases cell apoptosis through regulation of MELK targeted by miR-142-5p","volume":"42","author":"Xie","year":"2020","journal-title":"Genes Genom."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0019","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7150\/jca.61961","article-title":"LncRNA PCAT19 induced by SP1 and acted as oncogene in gastric cancer competitively binding to miR429 and upregulating DHX9","volume":"13","author":"Xiao","year":"2022","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101329_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1615\/CritRevEukaryotGeneExpr.2022043175","article-title":"Long non-coding RNA PCAT19 regulates the malignant progression of bladder cancer through the miR-335-5p\/IER2 Axis","volume":"32","author":"Wang","year":"2022","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101329_bib0021","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41416-020-0742-9","article-title":"Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis","volume":"122","author":"Acha-Sagredo","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0022","article-title":"An immune-related long noncoding RNA signature as a prognostic biomarker for human endometrial cancer","volume":"2021","author":"Wang","year":"2021","journal-title":"J. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101329_bib0023","doi-asserted-by":"crossref","first-page":"11971","DOI":"10.1002\/cam4.5872","article-title":"Inhibition of lncRNA PCAT19 promotes breast cancer proliferation","volume":"12","author":"Feng","year":"2023","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101329_bib0024","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.31557\/APJCP.2022.23.8.2735","article-title":"Evaluation of miRNA 223\/125a and COBLL1 expressions and ROR-1 levels as reliable markers in B- chronic lymphocytic leukemia","volume":"23","author":"Hussein","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0025","article-title":"MicroRNA biomarker hsa-miR-195-5p for detecting the risk of lung cancer","volume":"2020","author":"Li","year":"2020","journal-title":"Int. J. Genom."},{"key":"10.1016\/j.ctarc.2026.101329_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103211","article-title":"MiR-195-3p inhibits cell proliferation in cervical cancer by targeting BCDIN3D","volume":"143","author":"Jin","year":"2021","journal-title":"J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101329_bib0027","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3892\/ijo.2016.3608","article-title":"MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K\/Akt and Raf\/MEK\/ERK signaling pathways","volume":"49","author":"Sun","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101329_bib0028","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3892\/or.2017.5875","article-title":"MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1","volume":"38","author":"Shuang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101329_bib0029","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s12253-019-00655-8","article-title":"Differential analysis of lncRNA, miRNA and mRNA expression profiles and the prognostic value of lncRNA in esophageal cancer","volume":"26","author":"Liu","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0030","first-page":"120","article-title":"The expression and correlation of miR-195, miR-125 and calreticulin in diffuse large B-Cell lymphoma","volume":"31","author":"Li","year":"2023","journal-title":"Zhongguo Shi. Yan. Xue. Ye. Xue. Za. Zhi."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101329_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-025-06195-w","article-title":"Clinical implications of miR-195 in cancer: mechanisms, potential applications, and therapeutic strategies","volume":"151","author":"Xu","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101329_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.681717","article-title":"Molecular interplays between cell invasion and radioresistance that lead to poor prognosis in head-neck cancer","volume":"11","author":"You","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101329_bib0033","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3390\/cancers15092504","article-title":"Integrins and the metastasis-like dissemination of acute lymphoblastic leukemia to the central nervous system","volume":"15","author":"Modvig","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101329_bib0034","article-title":"Overexpression of SNTG2, TRAF3IP2, and ITGA6 transcripts is associated with osteoporotic vertebral fracture in elderly women from community","volume":"8","author":"Jales Neto","year":"2020","journal-title":"Mol. Genet. Genom. Med."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101329_bib0035","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.3390\/ijms23105848","article-title":"Epithelial\u2013mesenchymal transition (EMT) 2021","volume":"23","author":"Manfioletti","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101329_bib0036","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41571-025-01058-2","article-title":"EMT and cancer: what clinicians should know","volume":"22","author":"Thompson","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0037","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101329_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.720227","article-title":"E-cadherin: an important functional molecule at respiratory barrier between defence and dysfunction","volume":"12","author":"Yuksel","year":"2021","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0039","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3126\/jpn.v13i1.42969","article-title":"Correlation of expression of Cyclin D1 and E-cadherin with gleason grade, serum prostate specific antigen levels and prostatic volume in prostatic carcinoma","volume":"13","author":"Aatirah","year":"2023","journal-title":"J. Pathol. Nepal"},{"key":"10.1016\/j.ctarc.2026.101329_bib0040","first-page":"437","article-title":"Prostate cancer: prevention, risk factors, pathophysiology","volume":"12","author":"Obeagu","year":"2023","journal-title":"J. Biomed. Innov."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101329_bib0041","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/enj.enj_6_25","article-title":"Prostate cancer screening knowledge and attitude among male patients","volume":"22","author":"Abdelhafez","year":"2025","journal-title":"Egypt. Nurs. J."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101329_bib0042","first-page":"381","article-title":"Effect of prostatic cancer educational program on patients' health outcomes","volume":"6","author":"Elhoty","year":"2025","journal-title":"Int. Egypt. J. Nurs. Sci. Res."},{"key":"10.1016\/j.ctarc.2026.101329_bib0043","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/mmr.2022.12787","article-title":"Role of single nucleotide polymorphisms of the HSD3B1 gene (rs6203 and rs33937873) in the prediction of prostate cancer risk","volume":"26","author":"Amrousy","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ctarc.2026.101329_bib0044","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","article-title":"Non-coding RNAs in disease: from mechanisms to therapeutics","volume":"25","author":"Nemeth","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ctarc.2026.101329_bib0045","article-title":"The role of LncRNA-mediated autophagy in cancer progression","volume":"12","author":"Liu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101329_bib0046","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cell.2018.06.003","article-title":"Biology and clinical implications of the 19q13 aggressive prostate cancer susceptibility locus","volume":"174","author":"Gao","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101329_bib0047","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2018.06.014","article-title":"Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19","volume":"174","author":"Hua","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101329_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1435717","article-title":"PCAT19: the role in cancer pathogenesis and beyond","volume":"12","author":"Hu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ctarc.2026.101329_bib0049","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3892\/or.2016.4797","article-title":"Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ctarc.2026.101329_bib0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12967-015-0650-6","article-title":"MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells","volume":"13","author":"Wu","year":"2015","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0051","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13046-015-0209-7","article-title":"MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma","volume":"34","author":"Guo","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101329_bib0052","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.21037\/tcr-20-1083","article-title":"hsa-miR-195-5p inhibits cell proliferation of human thyroid carcinoma cells via modulation of p21\/cyclin D1 axis","volume":"9","author":"Liu","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0053","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1080\/21655979.2021.1963908","article-title":"miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101329_bib0054","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s12010-022-04279-8","article-title":"miR-195-5p targets CDK1 to regulate new DNA synthesis and inhibit the proliferation of hepatocellular carcinoma cells","volume":"195","author":"Zhou","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ctarc.2026.101329_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101289","article-title":"Chondrocyte-derived exosomal miR-195 inhibits osteosarcoma cell proliferation and anti-apoptotic by targeting KIF4A in vitro and in vivo","volume":"16","author":"Lu","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ctarc.2026.101329_bib0056","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.2147\/OTT.S242608","article-title":"miR-195 serves as a tumor suppressor in the progression of liposarcoma by targeting OSBP","volume":"13","author":"Cao","year":"2020","journal-title":"Onco Targets. Ther."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101329_bib0057","first-page":"659","article-title":"MiR-195-5p suppresses gastric adenocarcinoma cell progression via targeting OTX1","volume":"38","author":"Hu","year":"2023","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0058","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2257538","article-title":"ATG9A modulated by miR-195-5p can boost the malignant progression of cervical cancer cells","volume":"18","author":"Liu","year":"2023","journal-title":"Epigenetics"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101329_bib0059","first-page":"2528","article-title":"Mechanisms of miR-195-5p and FOXK1 in rat xenograft models of non-small cell lung cancer","volume":"13","author":"Niu","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101329_bib0060","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.13861","article-title":"PM 2.5 regulates the progression of lung adenocarcinoma through the axis of HCG18, miR-195 and ATG14","volume":"51","author":"Luo","year":"2024","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ctarc.2026.101329_bib0061","first-page":"11369","article-title":"Comprehensive analysis of integrin \u03b1v\u03b23\/\u03b16\u03b21 in prognosis and immune escape of prostate cancer","volume":"15","author":"Liu","year":"2023","journal-title":"Aging"},{"issue":"13","key":"10.1016\/j.ctarc.2026.101329_bib0062","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/cancers15133466","article-title":"Regulation and functions of \u03b16-integrin (CD49f) in cancer biology","volume":"15","author":"Khademi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101329_bib0063","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1158\/0008-5472.CAN-14-2155","article-title":"MiR-25 modulates invasiveness and dissemination of human prostate cancer cells via regulation of Av- and A6-integrin expression","volume":"75","author":"Zoni","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101329_bib0064","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-016-0510-x","article-title":"ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models","volume":"15","author":"Brooks","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101329_bib0065","article-title":"Integrin alpha 6\/Akt\/Erk signaling is essential for human breast cancer resistance to radiotherapy","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101329_bib0066","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/ijc.30854","article-title":"P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1","volume":"141","author":"Laudato","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101329_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100348","article-title":"LncRNA SNHG16 promotes epithelial-mesenchymal transition by upregulating ITGA6 through miR-488 inhibition in osteosarcoma","volume":"27","author":"Bu","year":"2021","journal-title":"J. Bone Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101329_bib0068","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41419-017-0258-2","article-title":"miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K\/AKT pathway in gallbladder carcinoma","volume":"9","author":"Jin","year":"2018","journal-title":"Cell Death. Dis."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101329_bib0069","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.3390\/cancers13112804","article-title":"Molecular pathogenesis and regulation of the miR-29-3p-family: involvement of ITGA6 and ITGB1 in intra-hepatic cholangiocarcinoma","volume":"13","author":"Hozaka","year":"2021","journal-title":"Cancers"},{"issue":"01","key":"10.1016\/j.ctarc.2026.101329_bib0070","first-page":"14","article-title":"Immunohistochemical expression status of HER2\/neu and E-cadherin in prostate adenocarcinoma: a cross-sectional study","volume":"13","author":"Reddy","year":"2024","journal-title":"Natl. J. Lab. Med."},{"key":"10.1016\/j.ctarc.2026.101329_bib0071","article-title":"E-cadherin, N-cadherin and ADAM12 in localized prostate cancer: a clinicopathological study","volume":"273","author":"P\u00e9rez-Barraza","year":"2025","journal-title":"Pathol. Res. Pr."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0072","first-page":"198","article-title":"Prognostic value of twist-1, E-cadherin and EZH2 in prostate cancer: an immunohistochemical study","volume":"1","author":"Abdelrahman","year":"2017","journal-title":"Turk. Patoloji. Derg."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101329_bib0073","doi-asserted-by":"crossref","DOI":"10.1080\/20565623.2025.2494972","article-title":"Dysadherin expression in prostatic adenocarcinoma and its relationship with E-cadherin and \u03b2-catenin","volume":"11","author":"Limani","year":"2025","journal-title":"Future Sci. Oa"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:47:25Z","timestamp":1790912845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":73,"alternative-id":["S2468294226002406"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101329","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of PCAT19, miR-195, ITGA6, and E-cadherin in prostate cancer: a preliminary tissue-based study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101329"}}